首页|血清GDF-15、CXCL9、AFR水平与急性肺栓塞患者病情严重程度及预后的关系

血清GDF-15、CXCL9、AFR水平与急性肺栓塞患者病情严重程度及预后的关系

扫码查看
目的:探讨急性肺栓塞(APE)患者血清生长分化因子-15(GDF-15)、CXC趋化因子配体9(CXCL9)、白蛋白/纤维蛋白原比值(AFR)表达水平与病情严重程度及预后的关系。方法:选取2020年1月至2022年12月西安交通大学第一附属医院收治的APE患者165例,并根据病情严重程度分为低危组(90例)、中危组(45例)、高危组(30例)。另选取同期50例健康体检者作为对照组。比较各组血清GDF-15、CXCL9、AFR水平,并分析血清GDF-15、CXCL9、AFR水平与APE患者病情严重程度的关系。随访至2023年5月31日,以患者死亡或随访时间结束为终点事件,根据随访结果分为生存组(145例)、死亡组(20例)。采用多元Cox回归分析APE患者预后不良的危险因素,绘制受试者工作特征曲线(ROC)评估血清GDF-15、CXCL9、AFR预测APE患者预后不良的价值。结果:APE患者血清GDF-15、CXCL9水平均高于对照组,AFR水平低于对照组,且随着病情加重,APE患者血清GDF-15、CXCL9水平逐渐升高,AFR水平逐渐降低,各组间差异有统计学意义(P<0。05)。APE患者血清GDF-15、CXCL9水平与病情严重程度均呈正相关(r=0。548、0。559,P<0。05),AFR水平与病情严重程度呈负相关(r=-0。480,P<0。05)。死亡组年龄≥60岁比例、中高危比例及血清D-D、GDF-15、CXCL9水平均高于生存组,AFR水平低于生存组,组间差异有统计学意义(P<0。05)。年龄≥60 岁(HR=2。252,95%CI=1。548~2。921)、中高危(HR=2。277,95%CI=1。703~2。852),D-D 水平高(HR=2。326,95%CI=1。652~2。999)、GDF-15 水平高(HR=2。452,95%CI=1。778~3。126)、CXCL9 水平高(HR=2。282,95%CI=1。512~3。052),AFR 水平低(HR=2。363,95%CI=1。472~3。254)是APE患者预后不良的危险因素(P<0。05)。血清GDF-15、CXCL9、AFR预测APE患者预后不良的AUC分别为0。880、0。900、0。883;三项联合检测预测的AUC为0。931,高于单项指标(P<0。05)。结论:APE患者血清GDF-15、CXCL9水平升高,AFR水平降低,并与病情严重程度及预后均有关,联合检测GDF-15、CXCL9、AFR有助于APE病情及预后评估。
Relationship between the Levels of Serum GDF-15,CXCL9,AFR and the Severity and Prognosis in Patients with Acute Pulmonary Embolism
Objective:To investigate the relationship between the expression levels of serum growth differentiation factor-15(GDF-15),CXC chemokine ligand 9(CXCL9),albumin/fibrinogen ratio(AFR)and the severity and prognosis in patients with acute pul-monary embolism(APE).Methods:165 APE patients admitted to the The First Affiliated Hospital of Xi'an Jiaotong University from Jan-uary 2020 to December 2022 were selected and divided into low risk group(90 cases),medium risk group(45 cases),and high-risk group(30 cases)based on the severity of the condition.Another 50 healthy individuals in the same period were selected as the control group.Compare the levels of serum GDF-15,CXCL9,AFR in each group,and analyze the relationship between the levels of serum GDF-15,CXCL9,AFR and the severity in APE patients.Follow up until May 31,2023,with patient death or the end of follow-up time as the end-point event,divided into survival group(145 cases)and death group(20 cases)based on the follow-up results.Multiple Cox regression analysis was used to analyze the risk factors for poor prognosis in APE patients;ROC was used to evaluate the value of GDF-15,CXCL9,AFR in predicting the poor prognosis of APE patients.Results:The levels of serum GDF-15,CXCL9 in APE patients were higher than those in the control group,the levels of AFR were lower than those in the control group(P<0.05);As the condition worsens,the levels of serum GDF-15,CXCL9 were increased in APE patients,the levels of AFR was decreased(P<0.05).The levels of serum GDF-15,CX-CL9 in APE patients were positively correlated with the severity(r=0.548,0.559,P<0.05),the levels of AFR was negatively correlated with the severity(r=-0.480,P<0.05).The proportion of Age ≥ 60 years and medium to high risk,and the levels of serum D-D,GDF-15,CXCL9 in the death group were higher than those in the survival group,the levels of AFR was lower than those in the survival group(P<0.05).Age ≥ 60 years(HR=2.252,95%CI=1.548~2.921),medium to high risk(HR=2.277,95%CI=1.703~2.852),high D-D levels(HR=2.326,95%CI=1.652~2.999),high GDF-15 levels(HR=2.452,95%CI=1.778~3.126),high CXCL9 levels(HR=2.282,95%CI=1.512~3.052),and low AFR levels(HR=2.363,95%CI=1.472~3.254)were risk factors for poor prognosis in APE patients(P<0.05).The AUC of GDF-15,CXCL9,AFR in predicting the poor prognosis of APE patients were 0.880,0.900,and 0.883;The AUC of the three combined detection was 0.931,was higher than the single indicator(P<0.05).Conclusions:The levels of serum GDF-15,CXCL9 were in-creased,the levels of AFR was decreased in APE patients,which were correlated with the severity and prognosis.The combined detec-tion of GDF-15,CXCL9,and AFR can helpful evaluate the severity and prognosis of APE.

Acute pulmonary embolismGrowth differentiation factor-15CXC chemokine ligand 9Albumin/fibrinogen ratioPrognosis

庞宏刚、孟燕、王盼兴、付博文、胡会社

展开 >

西安交通大学第一附属医院周围血管科 陕西西安 710061

急性肺栓塞 生长分化因子-15 CXC趋化因子配体9 白蛋白/纤维蛋白原比值 预后

陕西省重点研发计划

2021SF-149

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(7)
  • 30